DUBLIN–(BUSINESS WIRE)–The “Pressure Ulcers Market By Type, By Treatment Type, By End user: Global Opportunity Analysis and Industry Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.
The global pressure ulcers market was valued at $3,720.8 million in 2021, and is projected to reach $5,612.2 million by 2031, registering a CAGR of 4.2% from 2022 to 2031.
Pressure ulcers are also called as bed sores, pressure sores or decubitus ulcer are injuries to the skin and tissue due to prolonged pressure or pressure with friction on the skin. Pressure ulcers occurs most commonly on the skin present over sacrum, heels, hips and coccyx.
The other affected sites are knees, elbows, ankles and back of cranium. Pressure ulcers develop in individuals who have sedentary lifestyle, continuously use wheelchair and those who are immobilized due to chronic diseases. Early-stage diagnosis enables treatments and reduce complications associated with pressure ulcers such as cellulitis, sepsis, bone and joint infections.
The pressure ulcers market driven by increasing prevalence of pressure ulcer, rise in geriatric population as they are more susceptible to develop pressure ulcers, rise in awareness about availability of treatments for pressure ulcers, and increasing demand for wound care dressings product boosts growth of the market. For instance, according to U.S Department of Health and Human Wound Care Dressings, around 2.5 million population of U.S affected by pressure ulcers in 2020. Moreover, according to Wound Management and Prevention, about 71% pressure ulcers develop in patients older than 70 years.
However, high cost of treatments, side effects associated with the drug treatments such as upset stomach, nausea and blood pressure hinder the growth of the market.
The global pressure ulcers market is segmented into type, treatment type, end user and region. By type the market is categorized into stage 1, stage 2, stage 3, stage 4 and deep tissue injuries. Depending on treatment type, it is fragmented into wound care dressing, wound care devices and others. On the basis of end user, it is divided into hospitals, homecare and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pressure ulcers market analysis from 2021 to 2031 to identify the prevailing pressure ulcers market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pressure ulcers market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pressure ulcers market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Stage 1
Stage 2
Stage 3
Stage 4
Deep tissue injury
By Treatment Type
Wound Care Dressing
type
Foam Dressings
Hydrocolloid Dressings
Alginate Dressings
Other Dressings
Wound Care Devices
type
Therapy Devices
Others
Others
By End user
Hospitals
Homecare
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of LAMEA
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
3M Company
Abercrombie & Fitch Co (Hollister)
Anhui Jinye Industrial Co., Ltd
B. Braun Melungeon AG
Baxter International (Hill-Rom Holdings, Inc)
Cardinal Health Inc.
Coloplast Group
ConvaTec Group Plc
Essity (BSN medical)
Integra LifeSciences (Derma Sciences Inc)
Johnson and Johnson
Smith & Nephew plc
Stryker Corp
Tissue Regenix
Investor AB (Molnlycke Healthcare AB)
Wego Group (Foosin Medical Supplies Inc., Ltd.)
Shandong Chuangkang Biotechnology Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/vjddvr
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
